High Net Worth Advisory Group LLC Nuvalent, Inc. Transaction History
High Net Worth Advisory Group LLC
- $359 Million
- Q2 2025
A detailed history of High Net Worth Advisory Group LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, High Net Worth Advisory Group LLC holds 3,000 shares of NUVL stock, worth $231,690. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,000
Previous 3,000
-0.0%
Holding current value
$231,690
Previous $219,000
4.11%
% of portfolio
0.06%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding NUVL
# of Institutions
217Shares Held
60.9MCall Options Held
311KPut Options Held
175K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.39 Billion32.3% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.27MShares$407 Million19.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$343 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$234 Million0.01% of portfolio
-
Commodore Capital LP New York, NY1.86MShares$143 Million12.88% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.32B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...